Recombinant JAK2 anticorps (pTyr1007, pTyr1008) (Alexa Fluor 350)
Aperçu rapide pour Recombinant JAK2 anticorps (pTyr1007, pTyr1008) (Alexa Fluor 350) (ABIN7765667)
Antigène
Voir toutes JAK2 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr1007, pTyr1008
-
Fonction
- Conjugated JAK2 (Phospho-Tyr1007/Tyr1008) Rabbit mAb
-
Specificité
- Phospho-JAK2 (Y1007 + Y1008) Antibody detects endogenous levels of total Phospho-JAK2 (Y1007 + Y1008)
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human Phospho-JAK2 (Y1007 + Y1008)
-
-
-
-
Indications d'application
- most applications: 1: 50 - 1: 250
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Protect from light!
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C in dark for 6 months
-
-
- JAK2 (Janus Kinase 2 (JAK2))
-
Autre désignation
- JAK2
-
Sujet
- EC 2.7.10.2, JAK-2, JAK2, Janus kinase 2, kinase Jak2,
-
Poids moléculaire
- 130kDa
-
UniProt
- O60674
-
Pathways
- Signalistation JAK/STAT, Signalisation RTK, Interferon-gamma Pathway, Positive Regulation of Peptide Hormone Secretion, Intracellular Steroid Hormone Receptor Signaling Pathway, Response to Growth Hormone Stimulus, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling, Unfolded Protein Response
Antigène
-